Recommendation of the Society for Transfusion Medicine No. 20 Cold red blood cell antibodies testing before cardiothoracic surgery on cardiopulmonary bypass

Czech version

Authors: M. Králová ¹; J. Masopust ²; M. Písačka ³; V. Řeháček ⁴; P. Turek ⁵
Authors‘ workplace: Pracovní skupina STL ^*; Ústav hematologie a krevní transfuze, Praha ¹; Transfuzní oddělení, Krajská zdravotní, a. s. – Masarykova nemocnice v Ústí nad Labem, o. z. ²; Ústav hematologie a krevní transfuze, Praha ³; Transfuzní oddělení, FN Hradec Králové ⁴; Transfúzní oddělení, Fakultní Thomayerova nemocnice, Praha ⁵
Published in: Transfuze Hematol. dnes,32, 2026, No. Ahead of Print, p. 1-2.
Category: Best Practices
doi: https://doi.org/10.48095/cctahd202601

Overview

Cold red blood cell antibodies are usually clinically insignificant. However, they may have an adverse clinical impact in patients undergoing cardiac surgery with the use of cardiopulmonary bypass with cooling of the patient‘s blood. We present consensus recommendation for the screening and titration of cold red blood cell antibodies in these patients.

Keywords:

cardiac surgery – Cardiopulmonary bypass – cold RBC antibodies

Labels

Haematology Internal medicine Clinical oncology

Concurrent occurrence of BCR::ABL1-positive chronic myeloid leukaemia and Philadelphia-negative myeloproliferative neoplasm

Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients

Acute myeloid leukemia – how the approach to diagnosis, risk stratification, and treatment options has changed

Antifungal prophylaxis in patients with acute myeloid leukaemia treated with venetoclax and azacitidine

Article was published in

Transfusion and Haematology Today

2026 Issue Ahead of Print